Regis [RGS] vs Medifast [MED] Detailed Stock Comparison
Regis
NASDAQ
Loading...
Medifast
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Regis wins in 9 metrics, Medifast wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Regis | Medifast | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 0.52 | 42.88 | Regis |
| Price-to-Book Ratio | 0.69 | 0.67 | Medifast |
| Debt-to-Equity Ratio | 535.95 | 6.05 | Medifast |
| PEG Ratio | 0.00 | -0.33 | Medifast |
| EV/EBITDA | 16.52 | -0.16 | Medifast |
| Profit Margin (TTM) | 49.34% | 0.76% | Regis |
| Operating Margin (TTM) | 9.87% | -1.01% | Regis |
| EBITDA Margin (TTM) | 9.87% | N/A | N/A |
| Return on Equity | 548.07% | 1.73% | Regis |
| Return on Assets (TTM) | 2.48% | 2.88% | Medifast |
| Free Cash Flow (TTM) | $-2.42M | $17.02M | Medifast |
| 1-Year Return | -16.05% | -29.18% | Regis |
| Price-to-Sales Ratio (TTM) | 0.24 | 0.32 | Regis |
| Enterprise Value | $402.28M | $-4.30M | Regis |
| EV/Revenue Ratio | 2.02 | -0.01 | Medifast |
| Gross Profit Margin (TTM) | 36.96% | 72.61% | Medifast |
| Revenue per Share (TTM) | $85 | $44 | Regis |
| Earnings per Share (Diluted) | $37.87 | $0.33 | Regis |
| Beta (Stock Volatility) | 1.69 | 0.82 | Medifast |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Regis vs Medifast Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Regis | 0.52% | 0.10% | -7.81% | -9.95% | -17.44% | -18.42% |
| Medifast | -3.43% | 7.28% | 2.61% | 1.00% | -0.98% | -18.16% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Regis | -16.05% | -36.32% | -89.34% | -91.73% | 14.08% | -51.70% |
| Medifast | -29.18% | -89.47% | -91.51% | -49.46% | -49.59% | 243.45% |
Performance & Financial Health Analysis: Regis vs Medifast
| Metric | RGS | MED |
|---|---|---|
| Market Information | ||
| Market Cap | $47.67M | $155.52M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 6,060 | 198,340 |
| 90 Day Avg. Volume | 10,993 | 211,303 |
| Last Close | $19.36 | $13.66 |
| 52 Week Range | $15.00 - $29.28 | $11.57 - $21.98 |
| % from 52W High | -33.88% | -37.83% |
| All-Time High | $465.40 (Oct 28, 2019) | $336.99 (May 24, 2021) |
| % from All-Time High | -95.84% | -95.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.16% | -0.37% |
| Quarterly Earnings Growth | 0.16% | -0.37% |
| Financial Health | ||
| Profit Margin (TTM) | 0.49% | 0.01% |
| Operating Margin (TTM) | 0.10% | -0.01% |
| Return on Equity (TTM) | 5.48% | 0.02% |
| Debt to Equity (MRQ) | 535.95 | 6.05 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $28.18 | $21.04 |
| Cash per Share (MRQ) | $5.45 | $15.84 |
| Operating Cash Flow (TTM) | $12.08M | $4.15M |
| Levered Free Cash Flow (TTM) | $-1,657,125 | $10.69M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | $0.00 |
Valuation & Enterprise Metrics Analysis: Regis vs Medifast
| Metric | RGS | MED |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 0.52 | 42.88 |
| Forward P/E | -7.41 | 47.17 |
| PEG Ratio | 0.00 | -0.33 |
| Price to Sales (TTM) | 0.24 | 0.32 |
| Price to Book (MRQ) | 0.69 | 0.67 |
| Market Capitalization | ||
| Market Capitalization | $47.67M | $155.52M |
| Enterprise Value | $402.28M | $-4,297,744 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.02 | -0.01 |
| Enterprise to EBITDA | 16.52 | -0.16 |
| Risk & Other Metrics | ||
| Beta | 1.69 | 0.82 |
| Book Value per Share (MRQ) | $28.18 | $21.04 |
Financial Statements Comparison: Regis vs Medifast
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RGS | MED |
|---|---|---|
| Revenue/Sales | $56.96M | $115.73M |
| Cost of Goods Sold | $35.90M | $31.48M |
| Gross Profit | $21.05M | $84.25M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $5.02M | $-1.26M |
| EBITDA | $6.08M | $2.02M |
| Pre-Tax Income | $249,000 | $526,000 |
| Income Tax | $-1,000 | $1.30M |
| Net Income (Profit) | $250,000 | $-772,000 |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RGS | MED |
|---|---|---|
| Cash & Equivalents | $13.29M | $91.72M |
| Total Current Assets | $47.40M | $213.52M |
| Total Current Liabilities | $101.00M | $60.60M |
| Long-Term Debt | $305.32M | $8.45M |
| Total Shareholders Equity | $68.64M | $210.96M |
| Retained Earnings | $-14.53M | $176.01M |
| Property, Plant & Equipment | $255.36M | $46.32M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RGS | MED |
|---|---|---|
| Operating Cash Flow | $3.61M | $2.62M |
| Capital Expenditures | N/A | $-1.52M |
| Free Cash Flow | $5.88M | $1.88M |
| Debt Repayment | $-299,000 | N/A |
| Common Stock Repurchase | N/A | $-369,000 |
Short Interest & Institutional Ownership Analysis
| Metric | RGS | MED |
|---|---|---|
| Shares Short | 77,820 | 2.29M |
| Short Ratio | 6.01 | 11.35 |
| Short % of Float | 0.03% | 0.21% |
| Average Daily Volume (10 Day) | 6,060 | 198,340 |
| Average Daily Volume (90 Day) | 10,993 | 211,303 |
| Shares Outstanding | 2.28M | 10.94M |
| Float Shares | 2.16M | 9.15M |
| % Held by Insiders | 0.14% | 0.03% |
| % Held by Institutions | 0.31% | 0.80% |
Dividend Analysis & Yield Comparison: Regis vs Medifast
| Metric | RGS | MED |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | $2.74 |
| 3-Year Avg Dividend Yield | N/A | 1.43% |
| 3-Year Total Dividends | $0.00 | $8.22 |
| Ex-Dividend Date | N/A | Jun 26, 2023 |